Biogen Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $10.75B | $22.88B | $2.33B |
| FY2017 | $11.05B | $23.65B | $1.57B |
| FY2018 | $12.26B | $25.29B | $1.22B |
| FY2019 | $13.90B | $27.23B | $2.91B |
| FY2020 | $13.93B | $24.62B | $1.33B |
| FY2021 | $12.92B | $23.88B | $2.26B |
| FY2022 | $11.17B | $24.55B | $3.42B |
| FY2023 | $12.05B | $26.84B | $1.05B |
| FY2024 | $11.33B | $28.05B | $2.38B |
| FY2025 | $11.18B | $29.44B | $3.01B |